Metastasis directed radiotherapy versus standard of care for PSMA-PET diagnosed oligometastatic/oligoprogressive castration resistant prostate cancer
Abstract In recent years there has been a growing interest in metastasis directed radiotherapy (MDRT) in hormone-sensitive oligometastatic prostate cancer. The role of MDRT in castration resistant prostate cancer (CRPC) patients remains controversial. Our study retrospectively compared MDRT to stand...
Saved in:
| Main Authors: | Laura Bauersachs, Marcus Beck, Christian Furth, Felix Mehrhof, Holger Amthauer, Pirus Ghadjar, Julian M. M. Rogasch, Maria de Santis, Rana Tahbaz, Daniel Zips, Sebastian Zschaeck |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-09622-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
by: Himisha Beltran, et al.
Published: (2025-08-01) -
The tumour sink effect on 68Ga-PSMA-PET/CT in metastatic castration-resistant prostate cancer and its implications for PSMA-RPT: a sub-analysis of the 3TMPO study
by: Atefeh Zamanian, et al.
Published: (2025-07-01) -
The role of radiotherapy in the treatment of oligometastatic non-small cell lung cancer
by: Radovan Vojtišek
Published: (2025-01-01) -
LU-177-PSMA TREATMENT FOR METASTATIC PROSTATE CANCER – CASE EXAMPLES OF MIRACLE RESPONSES
by: K. Kairemo, et al.
Published: (2018-03-01) -
Screening and validation of key genes involved in castration-resistant prostate cancer based on transcriptomics sequencing
by: Guangquan Tong, et al.
Published: (2025-07-01)